Management to host conference call today at 4:30 p.m. ET LEXINGTON, Mass., May 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today reported its business update and financial results for the quarter ended March 31, 2026. Operational Highlights TakeAim Lymphoma Emavusertib is currently undergoing testing in combination with the Bruton's tyrosine kinase i

With biomedical, IoT, and imaging systems becoming networked endpoints, many health systems lack the staffing models, inventory visibility, and governance needed to manage risk and maintain clinical uptime. Info-Tech Research Group's newly released blueprint, Build a Resource Plan to Support Integrated IT and Biomedical Device Management , outlines a practical framework to help healthcare leaders align IT, Biomed, Security, and Clinical Operations around scalable device support. ARLINGTON, Va.,

New partnership with Reproductive Solutions ensures that Legacy offers the most reliable fertility workflows, supporting consistent at-home specimen collection and transport NEW YORK, May 12, 2026 /PRNewswire/ -- Legacy, the leading male fertility clinic and at-home sperm testing and cryopreservation platform, today announced the launch of an upgraded at-home semen collection kit featuring the ProteX™ Semen Collection Cup. The ProteX cup was developed in partnership with Reproductive Solutions,

VANCOUVER, BC, May 12, 2026 /PRNewswire/ - Scanbo® Technologies Inc. is a point-of-care intelligence platform combining diagnostics, clinical AI, and workflow tools to help clinicians make faster, safer decisions, has been recognized in the Government of British Columbia's official 2026 Life Sciences Ecosystem Map, published by the Ministry of Jobs, Economic Development and Innovation in collaboration with Life Sciences BC and Innovate BC . Continue Reading Scanbo Device (CNW Group/Scanbo Tech

Binaytara's 2026 National Summit on Hematologic Cancers returns to Nashville with the "Gray Zone" — faculty-facilitated, case-based sessions centered on the clinically contested scenarios where evidence is limited, expert opinion is divided, and standard management falls short. Deliberations are captured and published as peer-reviewed consensus guidance. And in a live "Impact Pitch", early-career hematologists compete for a share of $250,000 in research funding. EVENT: 2026 National Summit on He

MemorialCare Medical Group and MemorialCare Independent Physicians earned the American Heart Association's Gold Achievement Award for effectively managing cardiovascular risk in patients with Type 2 diabetes—a recognition that highlights their commitment to reducing heart disease and stroke. FOUNTAIN VALLEY, Calif., May 12, 2026 /PRNewswire/ -- MemorialCare Medical Group and MemorialCare Independent Physicians have received the American Heart Association's Target: Type 2 Diabetes Gold achievemen

BALTIMORE, May 12, 2026 /PRNewswire/ -- Vitamin®, a full-service branding, website design and development, digital marketing, and public relations agency, has been selected by The Mood Center as its agency of record for PR. The Mood Center is a leading mental health practice specializing in innovative neurotherapy treatments for depression and related conditions. The Mood Center offers advanced, evidence-based treatments, including IV ketamine therapy, SPRAVATO® (esketamine), a Johnson & Johnson

WASHINGTON, May 12, 2026 /PRNewswire/ -- Despite overwhelming support for clinical trials among primary care providers (PCPs), a new national survey from Patient Advocate Foundation (who announced a strategic merger with PAN Foundation in March 2026) highlights a significant disconnect between positive PCP attitudes and consistent patient engagement. Continue Reading Patient Advocate Foundation The research, conducted online by The Harris Poll, surveyed 503 actively practicing, board-certified U

ORLANDO, Fla.--(BUSINESS WIRE)--OutcomeRx Insurance Management Services, LLC today announced the launch of CGT Solutions Stop-Loss, a stand-alone medical stop-loss insurance product that reimburses covered expenses on qualified claims for Gene and CAR T-cell therapies for group health plans and their coordinating Stop-Loss carrier. This innovative solution, in addition to reimbursement for certain FDA approved Prescription Drugs, uniquely reimburses administration of the Prescription Drug and tr

PITTSBURGH, May 12, 2026 /PRNewswire/ -- "I wanted to create a discreet device to monitor vital signs, report GPS location, and provide wireless communication for a person having a medical emergency," said an inventor, from Douglaston, N.Y., "so I invented the HALO. My design would automatically summon life-saving emergency assistance." The patent-pending invention provides a wearable and wireless smart jewelry or accessory item that would offer real-time health monitoring and GPS location repor